codevelopment agreement
Thermo Fisher Scientific, AstraZeneca Team up to Develop CDx for Targeted Drugs
The next-generation sequencing based companion diagnostics will be paired with targeted therapies that are being developed for several diseases.
Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare
Sophia, which will trade on the Nasdaq, seeks to raise $100 million in an IPO, and separately announced a partnership with GE Healthcare.
Coeptis Garners Exclusive Codevelopment Rights from VyGen-Bio to NK-Cell Therapy, Diagnostic
The firm has the option to advance a cell therapy to protect CD38-positive NK cells from being destroyed by monoclonal antibodies and a test to identify best responders.
Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic
The two companies will codevelop the next-generation sequencing test for Kartos's MDM2 inhibitor, KRT-232, being studied in TP53 wild-type blood cancers.
The new partners seek to close the information loop by including providers, payors, and patients in biomarker-guided cancer therapy decisions.